Opiant Pharmaceuticals jumped nearly 30% yesterday on a favorable report from Zachs, making it the forth largest position in Todd Hagopian's Biotech Fund. Here's what Todd thinks of the news.
Opiant Pharmaceuticals jumped nearly 30% yesterday on a favorable report from Zachs, making it the forth largest position in Todd Hagopian's Biotech Fund. Here's what Todd thinks of the news.
Share this Article
Recommended